138 related articles for article (PubMed ID: 11826668)
1. [Free fatty acids: mediators of insulin resistance and atherosclerosis].
Castro Cabezas M; Erkelens DW; van Dijk H
Ned Tijdschr Geneeskd; 2002 Jan; 146(3):103-9. PubMed ID: 11826668
[TBL] [Abstract][Full Text] [Related]
2. PPAR agonists in the treatment of insulin resistance and associated arterial disease.
Camejo G
Int J Clin Pract Suppl; 2003 Mar; (134):36-44. PubMed ID: 12793596
[TBL] [Abstract][Full Text] [Related]
3. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
Julius U
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
[TBL] [Abstract][Full Text] [Related]
4. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes.
Boden G
Exp Clin Endocrinol Diabetes; 2003 May; 111(3):121-4. PubMed ID: 12784183
[TBL] [Abstract][Full Text] [Related]
5. [Macronutrients, fat mass, fatty acid flux and insulin sensitivity].
Ziegler O; Quilliot D; Guerci B; Drouin P
Diabetes Metab; 2001 Apr; 27(2 Pt 2):261-70. PubMed ID: 11452220
[TBL] [Abstract][Full Text] [Related]
6. Free fatty acids and insulin resistance.
Delarue J; Magnan C
Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):142-8. PubMed ID: 17285001
[TBL] [Abstract][Full Text] [Related]
7. Statins and diabetes.
Carmena R; Betteridge DJ
Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
[TBL] [Abstract][Full Text] [Related]
8. Gender differences in postprandial ketone bodies in normolipidemic subjects and in untreated patients with familial combined hyperlipidemia.
Halkes CJ; van Dijk H; Verseyden C; de Jaegere PP; Plokker HW; Meijssen S; Erkelens DW; Cabezas MC
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1875-80. PubMed ID: 12933534
[TBL] [Abstract][Full Text] [Related]
9. Fatty acids and insulin resistance in muscle and liver.
Kovacs P; Stumvoll M
Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):625-35. PubMed ID: 16311221
[TBL] [Abstract][Full Text] [Related]
10. Glucose-dependent insulin modulation of oscillatory lipolysis in perifused rat adipocytes.
Getty-Kaushik L; Richard AM; Corkey BE
Obes Res; 2005 Dec; 13(12):2058-65. PubMed ID: 16421338
[TBL] [Abstract][Full Text] [Related]
11. The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans.
Rigazio S; Lehto HR; Tuunanen H; Någren K; Kankaanpaa M; Simi C; Borra R; Naum AG; Parkkola R; Knuuti J; Nuutila P; Iozzo P
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E413-9. PubMed ID: 18505832
[TBL] [Abstract][Full Text] [Related]
12. Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage.
Raz I; Eldor R; Cernea S; Shafrir E
Diabetes Metab Res Rev; 2005; 21(1):3-14. PubMed ID: 15386813
[TBL] [Abstract][Full Text] [Related]
13. Direct free fatty acid uptake into human adipocytes in vivo: relation to body fat distribution.
Shadid S; Koutsari C; Jensen MD
Diabetes; 2007 May; 56(5):1369-75. PubMed ID: 17287467
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid metabolism and vascular disease.
Semenkovich CF
Trends Cardiovasc Med; 2004 Feb; 14(2):72-6. PubMed ID: 15030793
[TBL] [Abstract][Full Text] [Related]
15. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
[TBL] [Abstract][Full Text] [Related]
16. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
Bocher V; Chinetti G; Fruchart JC; Staels B
J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
[TBL] [Abstract][Full Text] [Related]
17. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta.
Lam TK; Yoshii H; Haber CA; Bogdanovic E; Lam L; Fantus IG; Giacca A
Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E682-91. PubMed ID: 12217885
[TBL] [Abstract][Full Text] [Related]
18. Contribution of triglyceride-rich lipoproteins to plasma free fatty acids.
Miles JM; Nelson RH
Horm Metab Res; 2007 Oct; 39(10):726-9. PubMed ID: 17952834
[TBL] [Abstract][Full Text] [Related]
19. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo.
Park E; Wong V; Guan X; Oprescu AI; Giacca A
J Endocrinol; 2007 Nov; 195(2):323-31. PubMed ID: 17951543
[TBL] [Abstract][Full Text] [Related]
20. Insulin sensitivity indices of glucose and free fatty acid metabolism in obese children and adolescents in relation to serum lipids.
Reinehr T; Kiess W; Andler W
Metabolism; 2005 Mar; 54(3):397-402. PubMed ID: 15736120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
